The ROC curves suggest that FOSL2 has a predictive power for LUAD prognosis, similar to the findings of Wang et al., who found that FOSL2 promoted TGF-β1-induced migration in NSCLC, and that patients with higher FOSL2 expression had a significantly higher risk of premature death [54]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.